Effects of 1,25(OH)2D3 administration on bone in patients with renal failure.
Malluche
H H
HH
Department of Medicine, University of Kentucky Medical Center, Lexington.
Faugere
M C
MC
D002117:Calcitriol / Q000627:therapeutic use*; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*
D002117:Calcitriol